SCHEMBL26819455

SCHEMBL26819455

CC(C)C(=O)N1CCN(C(=O)c2ccsc2)C(C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ HTT P42858 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ IDH1 O75874 2/20 0.43
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ PDK1 Q15118 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ PDK3 Q15120 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ GHSR Q92847 3/20 0.39
▸ TXK P42681 1/20 0.37
▸ JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26814614 0.82 HTT (0.56) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26814668 0.81 HTT (0.55) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26819672 0.80 GHSR (0.54) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26819931 0.80 SLC6A7 (0.53) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26819743 0.80 GHSR (0.55) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26819548 0.78 HTT (0.46) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26814685 0.78 DRD3 (0.58) TSHRHTTL3MBTL1KMT2AMEN1
SCHEMBL26814669 0.78 LMNA (0.79) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL26814626 0.77 HTT (0.79) LMNAALOX15TSHRHSD17B10HTT
SCHEMBL10939156 0.74 CHRNB2 (0.44) LMNAALOX15TSHRHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators PDE4A, PDE4B, PDE5A LMNA 4118/4885ALOX15 1872/4885TSHR 2647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback